Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Technology Scientific & Technical Instruments
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Dealing with impact of long waits for Medical Imaging
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(106)
•••
Comment by G1945Von Dec 23, 2022 1:44pm
94 Views
Post# 35189974

RE:RE:RE:RE:RE:RE:RE:RE:Dealing with impact of long waits for Medical Imaging

RE:RE:RE:RE:RE:RE:RE:RE:Dealing with impact of long waits for Medical Imaging
GrahamB wrote:

G1945V wrote:
Graham, you always resort to your talking points.

As the saying goes, you can lead a horse to water, but you can't make it drink.

Merry Christmas


G1945V

 

Ha ha
Did you ever wonder why a horse won't drink the water?

"Horses need fresh, clean water. If your horse isn’t drinking water, check their water sources. If it’s stale, has algae in it, or is dirty, your horse probably is going to refuse to drink it. You can keep your horse’s water fresh by having their buckets, troughs"
 
https://www.horsedrinker.com/horse-isnt-drinking-water/

Show me audited financials (now with a new auditor) with growing sales and decent margins and I will drink the water

Merry Christmas to all
Good luck to you longs-J do apppeeciate your commitment 
If you are right I salute you
take care 
enjoy the holidays
 


(won't drink) ..... the horse is not thirsty!

But I see that you are finally seeing some value in VPT.  Going in the right direction. Keep it up. (valuation)


G1945V
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities